| 000 | 01530 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518093713.0 | ||
| 264 | 0 | _c20201228 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1420-3049 | ||
| 024 | 7 |
_a10.3390/molecules25071567 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonçalves, Elaine C D | |
| 245 | 0 | 0 |
_aTerpenoids, Cannabimimetic Ligands, beyond the _h[electronic resource] |
| 260 |
_bMolecules (Basel, Switzerland) _cMar 2020 |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aBicyclic Monoterpenes _xchemistry |
| 650 | 0 | 4 |
_aCannabidiol _xchemistry |
| 650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xchemistry |
| 650 | 0 | 4 |
_aCannabis _xchemistry |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xdrug therapy |
| 650 | 0 | 4 |
_aDronabinol _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xchemistry |
| 650 | 0 | 4 |
_aNootropic Agents _xchemistry |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSesquiterpenes _xchemistry |
| 650 | 0 | 4 |
_aTerpenes _xchemistry |
| 700 | 1 | _aBaldasso, Gabriela M | |
| 700 | 1 | _aBicca, Maíra A | |
| 700 | 1 | _aPaes, Rodrigo S | |
| 700 | 1 | _aCapasso, Raffaele | |
| 700 | 1 | _aDutra, Rafael C | |
| 773 | 0 |
_tMolecules (Basel, Switzerland) _gvol. 25 _gno. 7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/molecules25071567 _zAvailable from publisher's website |
| 999 |
_c30803040 _d30803040 |
||